#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13670	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2132	634.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1406	1406	C	835	C	776	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13670	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2132	634.8	0	HET	.	.	.	A69G	.	69	69	A	291	291	A	755	A,G	563,138	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24980	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3380	732.1	0	.	n	.	0	T695C	SNP	695	695	T	941	941	C	748	C	684	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24980	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3380	732.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1583	1583	A	842	A,G	779,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24980	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3380	732.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2217	2217	C	770	C	714	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24980	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3380	732.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2291	2291	A	779	A	735	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24980	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3380	732.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2843	2843	C	757	C,A	709,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24980	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3380	732.1	0	HET	.	.	.	G694T,A	.	694	694	G	940	940	G	739	G,T,A	518,155,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	G5V	NONSYN	13	15	GGT	281	283	GTT	109;109;109	G;T;T	106;105;106	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	E12K	NONSYN	34	36	GAA	302	304	AAA	137;138;139	A;A;A	129;127;127	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	F31L	NONSYN	91	93	TTT	359	361	TTG	146;147;147	T;T;G	140;140;138	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	392	394	CAA	188;191;190	C;A;A	176;180;180	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	S75P	NONSYN	223	225	TCC	491	493	CCT	163;164;163	C;C;T	148;146;147	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	V87A	NONSYN	259	261	GTA	527	529	GCA	157;158;158	G;C;A	148;149;150	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	V130L	NONSYN	388	390	GTC	656	658	CTC	184;184;186	C,G;T;C	169,1;170;170	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	R135C	NONSYN	403	405	CGC	671	673	TGT	187;187;186	T;G;T	174;177;175	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	T137A	NONSYN	409	411	ACG	677	679	GCG	189;190;190	G;C;G	177;168;172	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	E151K	NONSYN	451	453	GAA	719	721	AAG	174;176;178	A;A,C;G	158;160,1;163	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	T152N	NONSYN	454	456	ACC	722	724	AAT	179;178;179	A;A;T	163;164;167	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	F218L	NONSYN	652	654	TTT	920	922	TTG	105;107;105	T;T;G	101;102;100	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	950	952	AGC	87;85;87	A;G;C	84;83;82	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1019	1021	CTG	91;93;91	C;T;G	83;82;82	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1025	1027	TCC	89;89;88	T;C;C	82;79;80	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1040	1042	GTG	105;106;108	G;T;G	93;90;95	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1462	folP	852	852	93.78	folP.l15.c17.ctg.1	1431	101.7	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1091	1093	GCG	135;134;130	G;C;G	121;120;119	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5222	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3318	156.7	1	SNP	p	S91F	1	.	.	271	273	TTC	544	546	TTC	175;177;177	T;T;C	158;159;161	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5222	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3318	156.7	1	SNP	p	D95G	1	.	.	283	285	GGC	556	558	GGC	172;168;164	G;G;C	152;151;149	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5222	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3318	156.7	1	SNP	p	G95N	0	.	.	283	285	GGC	556	558	GGC	172;168;164	G;G;C	152;151;149	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1504	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1295	115.7	1	SNP	p	G45D	0	.	.	133	135	GGC	412	414	GGC	174;172;172	G;G;C	166;161;165	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	818	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1019	79.8	0	.	n	.	0	A197.	DEL	197	197	A	614	614	A	190	A	178	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4874	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3006	161.4	1	SNP	p	D86N	0	.	.	256	258	GAC	585	587	GAC	193;196;196	G;A;C	179;180;183	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4874	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3006	161.4	1	SNP	p	R87I	0	.	.	259	261	CGT	588	590	CGT	202;204;201	C;G;T	188;187;186	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4874	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3006	161.4	1	SNP	p	R87W	0	.	.	259	261	CGT	588	590	CGT	202;204;201	C;G;T	188;187;186	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4874	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3006	161.4	1	SNP	p	S87R	1	.	.	259	261	CGT	588	590	CGT	202;204;201	C;G;T	188;187;186	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4874	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3006	161.4	1	SNP	p	S88P	0	.	.	262	264	TCC	591	593	TCC	202;200;199	T;C;C	185;184;183	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4084	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2663	152.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1517	1519	GGC	221;221;218	G;G;C	201;202;193	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3590	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2535	141.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1290	1292	GCA	198;200;198	G;C;A	182;180;180	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3590	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2535	141.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1293	1295	ATC	197;194;195	A;T;C	181;177;177	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3590	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2535	141.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1305	1307	GTG	205;207;207	G;T;G	186;188;188	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3590	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2535	141.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1305	1307	GTG	205;207;207	G;T;G	186;188;188	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3590	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2535	141.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1809	1811	ACC	173;172;171	A;C;C	152;154;153	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3590	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2535	141.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1863	1865	GCG	164;164;168	G;C;G	143;133;144	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3590	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2535	141.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1863	1865	GCG	164;164;168	G;C;G	143;133;144	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3590	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2535	141.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1986	1988	AGC	145;145;147	A;G;C	136;137;137	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3590	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2535	141.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1995	1997	GGC	135;136;133	G,A;G;C	125,1;128;125	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3590	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2535	141.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2013	2015	CCG	127;132;129	C,G;C,G;G	98,4;104,1;101	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5144	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3183	161.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1620	1622	CCG	215;212;217	C;C;G	183;189;186	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2070	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1762	117.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	499	499	C	141	C	130	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2670	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1603	165.5	0	.	p	.	0	G46S	NONSYN	136	138	GGC	550	552	AGC	186;186;188	A;G,A;C,A	171;172,1;171,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2670	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1603	165.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1045	1045	T	224	T	211	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2670	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1603	165.5	1	SNP	p	G120K	0	.	.	358	360	GGT	772	774	GGT	223;221;219	G;G;T	201;200;197	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2670	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1603	165.5	1	SNP	p	A121D	0	.	.	361	363	GCC	775	777	GCC	218;216;217	G;C;C	201;199;201	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2670	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1603	165.5	1	SNP	p	A121N	0	.	.	361	363	GCC	775	777	GCC	218;216;217	G;C;C	201;199;201	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9806	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4918	198.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1044	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1062	97.6	1	SNP	p	V57M	1	.	.	169	171	ATG	519	521	ATG	200;198;197	A;T;G	183;180;178	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
